Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma

被引:12
|
作者
Ikeda, Satoshi [1 ]
Naruse, Keishi [2 ]
Nagata, Chigusa [1 ]
Kuramochi, Masami [3 ]
Onuki, Takuya [3 ]
Inagaki, Masaharu [3 ]
Suzuki, Keiko [1 ]
机构
[1] Tsuchiura Kyodo Gen Hosp, Dept Pathol, Tsuchiura, Ibaraki 3000053, Japan
[2] Natl Hosp Org Natl Kochi Hosp, Dept Pathol, Kochi 7808077, Japan
[3] Tsuchiura Kyodo Gen Hosp, Dept Resp Surg, Tsuchiura, Ibaraki 3000053, Japan
关键词
immunocytochemistry; lung cytopathology; scoring; FACTOR-I; PULMONARY; P63; ADENOCARCINOMA; EXPRESSION; CANCER; BREAST; DELTA-NP63; SPECIMENS; CYTOLOGY;
D O I
10.3892/ol.2015.3045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to examine the effectiveness of immunostaining of cytological specimens in discerning squamous from non-squamous cell carcinoma. Various combinations of six antibodies were examined in order to determine the optimal combination for use in differential diagnosis. Immunostaining was performed using tumor imprint smears obtained from 70 lung carcinoma cases. The results were scored based on positive area and intensity. For objective evaluation, scores for thyroid transcription factor 1 (TTF-1), napsin A, and CK CAM5.2 were expressed with positive values, while those for p40, cytokeratin (CK) 5/6 and CK5 were expressed with negative values. Histograms were produced to evaluate which combination was the most effective in differentiating squamous cell carcinoma from adenocarcinoma. The sensitivity for these molecules in adenocarcinoma was 88% for TTF-1, 85% for napsin A, and 100% for CAM5.2. In squamous cell carcinomas, sensitivity was determined to be 90% for p40, 86% for CK5, and 76% for CK5/6. The specificity for these molecules was calculated as 100%, 95%, 43%, 98%, 100% and 95%, respectively. Each combination was evaluated for scoring and the values were averaged. The most effective combination for mode and mean was TTF-1, napsin A, p40, and CK5, for which all adenocarcinomas had a score >1, and all squamous cell carcinomas scored <-2. Immunostaining scoring may therefore be useful for the differential diagnosis of these carcinomas when a limited number of tumor cells are present.
引用
收藏
页码:2099 / 2104
页数:6
相关论文
共 50 条
  • [1] Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma
    Tran, Lena
    Mattsson, Johanna S. M.
    Nodin, Bjorn
    Jonsson, Per
    Planck, Maria
    Jirstrom, Karin
    Botling, Johan
    Micke, Patrick
    Brunnstrom, Hans
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (09) : 648 - 659
  • [2] Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40
    Hayashi, Takuo
    Takamochi, Kazuya
    Yanai, Yuka
    Mitani, Keiko
    Tomita, Hisashi
    Mogushi, Kaoru
    Suehara, Yoshiyuki
    Takahashi, Fumiyuki
    Suzuki, Kenji
    Saito, Tsuyoshi
    Yao, Takashi
    HUMAN PATHOLOGY, 2018, 78 : 177 - 181
  • [3] Diffuse coexpression of thyroid transcription factor-1 and p40 in a non-small cell carcinoma of the lung: Second case in the female population
    Martinez, Marta Segado
    Garcia, Gema Ruiz
    REVISTA ESPANOLA DE PATOLOGIA, 2024, 57 (02): : 120 - 122
  • [4] Napsin A/p40 Antibody Cocktail for Subtyping Non-Small Cell Lung Carcinoma on Cytology and Small Biopsy Specimens
    Nishino, Michiya
    Hoang, Mai P.
    Della Pelle, Patricia
    Morales-Oyarvide, Vicente
    Huynh, Tiffany G.
    Mark, Eugene J.
    Mino-Kenudson, Mari
    CANCER CYTOPATHOLOGY, 2016, 124 (07) : 472 - 484
  • [5] Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report
    Terada, Kazuhiro
    Menju, Toshi
    Date, Horoshi
    Haga, Hironori
    Yoshizawa, Akihiko
    THORACIC CANCER, 2024, 15 (12) : 1029 - 1033
  • [6] Evaluation of Napsin A, Cytokeratin 5/6, p63, and Thyroid Transcription Factor 1 in Adenocarcinoma Versus Squamous Cell Carcinoma of the Lung
    Whithaus, Kenneth
    Fukuoka, Junya
    Prihoda, Thomas J.
    Jagirdar, Jaishree
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (02) : 155 - 162
  • [7] ROLE OF P40 (ΔNP63), P63, THYROID TRANSCRITPION FACTOR-1 AND NAPSIN A IN DIFFERENTIAL DIAGNOSIS BETWEEN LUNG SQUAMOUS CELL CARCINOMA AND LUNG ADENOCARCINOMA
    Sun, Tingyi
    Xie, Hongjian
    Kong, Lingfei
    ACTA MEDICA MEDITERRANEA, 2014, 30 (04): : 923 - 927
  • [8] Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases
    Sharma, Rajni
    Wang, Yuting
    Chen, Li
    Gurda, Grzegorz T.
    Geddes, Susan
    Gabrielson, Edward
    Askin, Frederic
    Li, Qing Kay
    HUMAN PATHOLOGY, 2016, 54 : 8 - 16
  • [9] Role of p40 and cytokeratin 5/6 in the differential diagnosis of sinonasal undifferentiated carcinoma
    Singh, Lavleen
    Ranjan, Richa
    Arava, Sudheer
    Singh, M. K.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2014, 18 (05) : 261 - 265
  • [10] Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas
    Cheuk, W
    Kwan, MY
    Suster, S
    Chan, JKC
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (02) : 228 - 231